Alnylam Pharmaceuticals 2022 AWARD

January 19, 2022 | News

Alnylam Pharmaceuticals partners with the Rare Diseases Foundation to reward

an innovative project in the field of rare diseases with a grant of 20 000 €.

The project should address one or both of the following themes:

- Translational project developing an RNA interference approach and using a

animal or cell model expressing the targeted pathology.

- Innovative vectoring of interfering RNA targeting an organ or tissue.

Application deadline: March 31, 2022

To download the text of the Award: click here